EUVIMEDEUVIMED entdecken
Crossref

Plasma complement activation is associated with favourable prognosis in luminal metastatic breast cancer

A. Minery, H. Hamidi, S. Sayala Andrade Marques, S. Renault, L. Cabel, A. Vicent-Salomon, M.A. Dragon-Durey, L.T. Roumenina

European Journal of Cancer · 2026-11 · 248 · 117770

DOI: 10.1016/j.ejca.2026.117770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Minery und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Minery, A., Hamidi, H., Marques, S. S. A., Renault, S., Cabel, L., Vicent-Salomon, A., Dragon-Durey, M., & Roumenina, L. (2026). Plasma complement activation is associated with favourable prognosis in luminal metastatic breast cancer. European Journal of Cancer, 248, 117770. https://doi.org/10.1016/j.ejca.2026.117770

Vancouver

Minery A, Hamidi H, Marques SSA, Renault S, Cabel L, Vicent-Salomon A, et al. Plasma complement activation is associated with favourable prognosis in luminal metastatic breast cancer. European Journal of Cancer. 2026;248:117770. doi:10.1016/j.ejca.2026.117770

BibTeX
@article{Minery2026,
  author = {Minery, A. and Hamidi, H. and Marques, S. Sayala Andrade and Renault, S. and Cabel, L. and Vicent-Salomon, A. and Dragon-Durey, M.A. and Roumenina, L.T.},
  title = {Plasma complement activation is associated with favourable prognosis in luminal metastatic breast cancer},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117770},
  doi = {10.1016/j.ejca.2026.117770}
}
Kostenlos starten →